Attana
Biosensors for the pharma, diagnostic and academic societies.
Madrid Community of Madrid (HQ)
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | <1m | 1.4m | <1m |
% growth | (18 %) | 25 % | 60 % | (13 %) | 14 % | 63 % | (48 %) |
EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | (1.8m) | (1.4m) | (1.3m) |
% EBITDA margin | (125 %) | (100 %) | (75 %) | (129 %) | (200 %) | (100 %) | (170 %) |
Profit | (<1m) | (<1m) | (<1m) | (1.2m) | (1.9m) | (1.7m) | (1.5m) |
% profit margin | (175 %) | (120 %) | (88 %) | (157 %) | (213 %) | (115 %) | (202 %) |
EV / revenue | - | 10.3x | 17.8x | 42.9x | 18.5x | 3.5x | 4.4x |
EV / EBITDA | - | -10.3x | -23.8x | -33.4x | -9.3x | -3.5x | -2.6x |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | SEK6.4m | Early VC | |
€280k | Grant | ||
N/A | N/A | IPO | |
Total Funding | €984k |
Recent News about Attana
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.